No Data
Bernstein Maintains Vertex Pharmaceuticals(VRTX.US) With Hold Rating, Maintains Target Price $506
Is Wall Street Bullish or Bearish on Vertex Pharmaceuticals Stock?
RBC Capital Sticks to Their Hold Rating for Vertex Pharmaceuticals (VRTX)
Dyne, Avidity Initiated at Outperform by RBC on DM1 Drugs
In 2025, US Biotech stocks are expected to rise significantly. jpmorgan's top pick is vertex pharmaceuticals (VRTX.US).
Vertex pharmaceuticals (Vertex) ranked first on the list of US biotechnology stock selections for 2025 released by jpmorgan.
Vertex Leads J.P. Morgan's Top Biotech Picks List for 2025